GenMark Diagnostics to Participate in the Cowen Health Care Conference

CARLSBAD, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen Health Care Conference in Boston, Massachusetts.

GenMark’s management is scheduled to present on Tuesday, March 3, 2020 at 10:40am ET. Interested parties can access a live and archived webcast of the presentation at ir.genmarkdx.com.

About GenMark Diagnostics
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
[email protected]

You May Also Be Interested In

• Jyske Realkredit explores the possibilities of issuing a new euro denominated benchmark covered bond
• SK hynix Accelerates 40 Trillion won Share Repurchase and Cancellation Program, Pursues Shareholder Return Expansion to 'Over 50% of FCF'
• PlanRadar AI Agents Close the Gap Between What Happens on a Project and What Gets Done